| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Beone Medicines AG (BEIGF) has 1 insider with recent SEC Form 4 filings, including 0 buys and 2 sells. BEIGF is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| VP | 109.1K | $2.59M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 8, 2026 | Lee Chan Henry47 | SVP, General Counsel | Sale+OE | 332 | $311.59 | $103,447.88 | -100% | |
| Mar 11, 2026 | Lee Chan Henry47 | SVP, General Counsel | Sale+OE | 341 | $300.00 | $102,300.00 | -100% |